News All the latest news and information about the care, research, teaching and management we do at Vall d’Hebron Barcelona Hospital Campus. Don't miss any details! Fulltext search Search FUTURO project to improve sexual and reproductive health of young people in Angola ends 30/10/2024 Vall d’Hebron achieves the first fully robotic lung transplant 17/04/2023 COVID-19 vaccine generates memory immune cells in lungs 12/04/2023 Dr. María José Buzón co-chairs the GeSIDA congress with multiple Vall d'Hebron projects 01/12/2022 A study shows that 40% of patients with monkeypox have complications requiring treatment 10/08/2022 New drug could improve response to cancer treatments 06/07/2022 Different genes would explain the higher severity of acute kidney injury in males 08/06/2022 New Santiago Ramón y Cajal Chair 08/04/2022 Simplification of antiretroviral treatment will improve the quality of life of HIV patients 10/10/2021 40 years since the first HIV diagnosis in Spain 07/10/2021 New study shows that COVID-19 can damage the placenta of pregnant women 05/10/2021 Dr. Maria Luisa Aznar is invited to a meeting with the President of Angola and King Felipe VI on the occasion of Vall d'Hebron research projects in the African country 27/09/2021 Vall d'Hebron organizes a round table on zoonoses at the Healthio Research Day at Expoquimia 13/09/2021 A new mortality prediction calculator for patients with infective endocarditis could save lives 06/07/2021 Vall d’Hebron identifies memory immune cells in blood and lungs essential for the control of SARS-CoV-2 20/05/2021 Great participation of professionals from Vall d'Hebron in the 2nd National Congress of COVID-19 12/04/2021 Vall d'Hebron identifies a key protein to prevent breast cancer metastases 08/09/2020 Vall d’Hebron describes two cases of fetuses with edema in pregnant women with COVID-19 17/08/2020 A Vall d’Hebron study shows that 70% of residents and 56% of staff infected with SARS-CoV-2 in nursing homes are asymptomatic 01/07/2020 Vall d'Hebron participates in a clinical trial to evaluate the efficacy and safety of low-dose selinexor in patients with severe COVID-19 26/04/2020 Pagination 1 2 Next › Next page Last » Last page